Cardiovascular Clinical Trials
The Methodist Hospitals Heart and Vascular Institute is dedicated to delivering the best cardiovascular are in Northwest Indiana. That commitment extends to participating in these clinical trials and research focused on developing new treatments for heart and vascular conditions.
Galactic-HF: Global approach to lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure
Sponsor: Amgen
- Open For Enrollment 2017-2021
- Methodist IRB
- Heart failure
- $50 Patient payment
Victoria: Vericigut global study in subjects with heart failure with reduced ejection fraction
Sponsor: Merck
- Open For Enrollment 2017-2019
- Heart Failure
- WIRB
- $50 Patient payment
GUIDE-HF: Cardiomems; Hemodynamic- guided management of heart failure
Sponsor: St. Jude Medical
- Guided Heart Failure study
- Open for Enrollment 5/2018
- Methodist IRB
- No patient payment
Paradise MI: Prospective ARNI versus ACE inhibitor trial to determine superiority in reducing heart failure events after myocardial infarction
Sponsor: Norvartis
- Myocardial Infarction Trial
- Awaiting Enrollment Opening 12/2018
- Methodist IRB
- $50 Patient compensation.
HEARTIT: Heart Sounds Registry in Patients using the wearable Cardioverter Defibrillator
Sponsor: Zoll
- Heart Failure
- Open for enrollment
- Copernicus IRB
- No patient compensation
Please contact Kim Armstrong, RN, Clinical Research Coordinator, at the Heart Centers at 219-884-9180 or by email at theheartcenterlcka@yahoo.com.
CLICK HERE to meet the Methodist Physician Group cardiology specialists practicing near you.
Methodist Hospitals Heart and Vascular Institute
Northlake Campus: 600 Grant Street, Gary, IN 46402
Southlake Campus: 8701 Broadway, Merrillville, IN 46410 • 219-738-5330